Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 28, 2021

View Archived Issues

Selective functional impairment of HIV-specific CD8+ T cells heralds aborted HIV control

U.S. Department of Health & Human Services patents T-cell receptors against mutated RAS

New HDAC6 inhibitors identified at Chong Kun Dang Pharmaceutical

Hanyang University discovers MAPK10 inhibitors

New PDE4 inhibitors divulged by Suzhou Longbiotech Pharmaceuticals

TIMP-1 and CKM as biomarkers of therapeutic response for exon-skipping therapies in DMD

Ninjurin-1-associated eRNA linked to glioblastoma multiforme

Association between heterozygous variant in GRM1 gene and autosomal dominant cerebellar ataxia

New proteasome inhibitors show antimalarial promise

RNA therapeutic MC-30 shows efficacy in rodent models of HNSCC

Beam Therapeutics presents in vitro data on use of cytosine base editors for hepatitis B

NINDS grant supports Sinopia's IND-enabling studies of Parkinson's candidate

Targeting nigral SRY synthesis may be therapeutic for men with Parkinson's disease

Dare Bioscience awarded NICHD grant for DARE-LARC1 user-controlled contraceptive

Oblique reports in vivo data on aG13D monoclonal antibodies for colorectal cancer

Serotonin inhibition reduces tumor growth and increases CD8+ T-cell infiltration in tumor models

Diaprost licenses theranostic antibody hu5A10 to Radiopharm

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...